These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6841545)

  • 41. The use of aminopyridines in neurological disorders.
    Sedehizadeh S; Keogh M; Maddison P
    Clin Neuropharmacol; 2012; 35(4):191-200. PubMed ID: 22805230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The myasthenic syndrome: anaesthesia in a patient treated with 3.4 diaminopyridine.
    Telford RJ; Hollway TE
    Br J Anaesth; 1990 Mar; 64(3):363-6. PubMed ID: 1970263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of 4-aminopyridine and 2,4-diaminopyridine on the in vivo release of acetylcholine and dopamine in freely moving rats measured by intrastriatal dialysis.
    Damsma G; Biessels PT; Westerink BH; De Vries JB; Horn AS
    Eur J Pharmacol; 1988 Jan; 145(1):15-20. PubMed ID: 2832183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
    Sanders DB; Howard JF; Massey JM
    Ann N Y Acad Sci; 1993 Jun; 681():588-90. PubMed ID: 8357206
    [No Abstract]   [Full Text] [Related]  

  • 45. Angiographic and angioscopic observations of the arterial luminal changes induced by vasospasm.
    Uchida Y; Nakamura F; Tomaru T; Sonoki H; Sumino S; Sugimoto T
    Am Heart J; 1987 Nov; 114(5):1096-101. PubMed ID: 3673876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nicotinic antagonists produce differing amounts of tetanic fade in the isolated diaphragm of the rat.
    Gibb AJ; Marshall IG
    Br J Pharmacol; 1986 Nov; 89(3):619-24. PubMed ID: 2879597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poisoning with 4-aminopyridine: report of three cases.
    Spyker DA; Lynch C; Shabanowitz J; Sinn JA
    Clin Toxicol; 1980 Jun; 16(4):487-97. PubMed ID: 6250762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of adenosine and calcium entry blockers on 3,4-diaminopyridine-induced rhythmic contractions in dog coronary artery.
    Nakazawa M; Mustafa SJ
    Eur J Pharmacol; 1988 May; 149(3):345-9. PubMed ID: 3409957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antagonistic effects of neostigmine, 4-aminopyridine and 3,4-diaminopyridine on muscle relaxing effects of d-tubocurarine].
    Fukushima K; Aoki T; Ishikawa J
    Masui; 1983 Oct; 32(10):1236-40. PubMed ID: 6668654
    [No Abstract]   [Full Text] [Related]  

  • 51. 3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).
    Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():811-6. PubMed ID: 9668334
    [No Abstract]   [Full Text] [Related]  

  • 52. Improvement of 8-arm maze performance in aged Fischer 344 rats with 3,4-diaminopyridine.
    Davis HP; Idowu A; Gibson GE
    Exp Aging Res; 1983; 9(3):211-4. PubMed ID: 6641784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aminopyridines for symptomatic treatment in multiple sclerosis.
    Solari A; Uitdehaag B; Giuliani G; Pucci E; Taus C
    Cochrane Database Syst Rev; 2002; (4):CD001330. PubMed ID: 12804404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aminopyridines for symptomatic treatment in multiple sclerosis.
    Solari A; Uitdehaag B; Giuliani G; Pucci E; Taus C
    Cochrane Database Syst Rev; 2001; 2002(4):CD001330. PubMed ID: 11687106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potassium conductance of the resting squid axon and its blockage by clinical concentrations of general anaesthetics.
    Haydon DA; Requena J; Simon AJ
    J Physiol; 1988 Aug; 402():363-74. PubMed ID: 3236243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The actions of 3,4-diaminopyridine in bullfrog sympathetic ganglia.
    Apatoff B; Riker WK
    Brain Res; 1982 Dec; 252(2):277-86. PubMed ID: 6185176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of 2-aminopyridine fluorescence labeling in the analysis of in vivo and in vitro metabolism of dextran sulfate sodium by size-exclusion high-performance liquid chromatography.
    Araki Y; Andoh A; Fujiyama Y; Hata K; Makino J; Okuno T; Nakanura F; Bamba T
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):209-15. PubMed ID: 11334333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 4-Aminopyridine kinetics.
    Uges DR; Sohn YJ; Greijdanus B; Scaf AH; Agoston S
    Clin Pharmacol Ther; 1982 May; 31(5):587-93. PubMed ID: 7075108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium action potentials in rat fast-twitch and slow-twitch muscle fibres.
    Chiarandini DJ; Stefani E
    J Physiol; 1983 Feb; 335():29-40. PubMed ID: 6308219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of 3,4-diaminopyridine and tetraethylammonium on the pre- and post-junctional alpha-adrenoceptor mediated inhibitory actions of noradrenaline in the guinea-pig ileum.
    Bauer V
    Br J Pharmacol; 1985 May; 85(1):171-7. PubMed ID: 2411318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.